Dr. Howard Fillit: Why Alzheimer’s milestone, new research gives me hope for millions of patients and families
Many patient advocacy groups representing the 6 million Americans suffering from Alzheimer’s disease are hailing the FDA’s approval of a new treatment for Alzheimer’s, aducanamab – the first since 2003.